Literature DB >> 2930506

The structural basis for neutrophil inactivation of C1 inhibitor.

P A Pemberton1, R A Harrison, P J Lachmann, R W Carrell.   

Abstract

Limited proteolysis of C1 inhibitor (C1-INH) by neutrophil elastase, Pseudomonas elastase and snake venoms resulted in initial cleavage within the molecule's N-terminus followed by further cleavage within the molecule's C-terminally placed reactive centre. N-Terminal proteolysis occurred at peptide bonds 14-15, 36-37 and 40-41. This had no effect on either the inhibitory activity or the heat-stability of C1-INH. Proteolysis within the reactive centre occurred at peptide bonds 439-440, 440-441, 441-442 and 442-443. Cleavage at any one of these sites inactivated C1-INH and conferred enhanced heat-stability upon a previously heat-labile molecule. Released neutrophil proteinases also cleaved and inactivated C1-INH, suggesting that they may physiologically regulate C1-INH during inflammatory episodes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2930506      PMCID: PMC1138340          DOI: 10.1042/bj2580193

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Carboxy terminal fragment of human alpha-1-antitrypsin from hydroxylamine cleavage: homology with antithrombin III.

Authors:  R Carrell; M Owen; S Brennan; L Vaughan
Journal:  Biochem Biophys Res Commun       Date:  1979-12-14       Impact factor: 3.575

2.  Heat lability of alpha1-antitrypsin variants.

Authors:  J Lieberman
Journal:  Chest       Date:  1973-11       Impact factor: 9.410

3.  Characterization of the inactive fragment resulting from limited proteolysis of human alpha1-proteinase inhibitor by Crotalus adamanteus proteinase II.

Authors:  L F Kress; T Kurecki; S K Chan; M Laskowski
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

4.  Inactivation of human alpha 1-proteinase inhibitor by thiol proteinases.

Authors:  D Johnson; J Travis
Journal:  Biochem J       Date:  1977-06-01       Impact factor: 3.857

Review 5.  Active oxygen species and the functions of phagocytic leukocytes.

Authors:  J A Badwey; M L Karnovsky
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

6.  Identification of the cleavage sites resulting from enzymatic inactivation of human antithrombin III by Crotalus adamanteus proteinase II in the the presence and absence of heparin.

Authors:  L F Kress; J J Catanese
Journal:  Biochemistry       Date:  1981-12-22       Impact factor: 3.162

7.  The thrombin cleavage site in bovine antithrombin.

Authors:  H Jörnvall; W W Fish; I Björk
Journal:  FEBS Lett       Date:  1979-10-15       Impact factor: 4.124

8.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

9.  Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin.

Authors:  K Beatty; J Bieth; J Travis
Journal:  J Biol Chem       Date:  1980-05-10       Impact factor: 5.157

10.  Interaction of mouse macrophage elastase with native and oxidized human alpha 1-proteinase inhibitor.

Authors:  M J Banda; E J Clark; S Sinha; J Travis
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

View more
  12 in total

1.  Slp is an essential component of an EDTA-resistant activation pathway of mouse complement.

Authors:  C W van den Berg; P Démant; P C Aerts; H Van Dijk
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

2.  Ovalbumin and angiotensinogen lack serpin S-R conformational change.

Authors:  P E Stein; D A Tewkesbury; R W Carrell
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

3.  The effect of C1 inhibitor on myocardial ischemia and reperfusion injury.

Authors:  Fengxin Lu; Stacey M Fernandes; Alvin E Davis
Journal:  Cardiovasc Pathol       Date:  2012-06-16       Impact factor: 2.185

4.  Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers.

Authors:  K S Aulak; A E Davis; V H Donaldson; R A Harrison
Journal:  Protein Sci       Date:  1993-05       Impact factor: 6.725

5.  Rapid and sensitive techniques for identification and analysis of 'reactive-centre' mutants of C1-inhibitor proteins contained in type II hereditary angio-oedema plasmas.

Authors:  K S Aulak; R S Harrison
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

6.  Complement-mediated killing of microtumors in vitro.

Authors:  J Hakulinen; S Meri
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

7.  Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene.

Authors:  N J Levy; N Ramesh; M Cicardi; R A Harrison; A E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

8.  Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.

Authors:  E Eldering; C C Huijbregts; J H Nuijens; A J Verhoeven; C E Hack
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

9.  The equine major plasma serpin multigene family: partial characterization including sequence of the reactive-site regions.

Authors:  S D Patterson; K Bell; D C Shaw
Journal:  Biochem Genet       Date:  1991-10       Impact factor: 1.890

10.  Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein.

Authors:  R Zahedi; J J Bissler; A E Davis; C Andreadis; J J Wisnieski
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.